Literature DB >> 9855423

Maternal immunity and infant responses to immunization: factors influencing infant responses.

C A Siegrist1, P H Lambert.   

Abstract

The presence of maternally-derived antibodies at the time of immunization is known to interfere frequently with active immunization, with variable levels of clinical significance. Deciphering the rules as the basis of such inhibitory effects on infant vaccine responses would certainly contribute to the development of vaccination strategies for early life. These questions were addressed in murine neonatal or early life immunization models using various antigens (measles, tetanus, RSV) and antigen-presentation systems (peptides, proteins, live attenuated vaccines, live recombinant vectors or DNA plasmids) in the absence or presence of maternal antibodies. Factors identified as crucial determinants of maternal antibody-mediated effects on both live and non-live vaccines include the relative amount of maternal antibodies and of vaccine antigens present at immunization, antigenic conformation, epitope specificity and the distinct influence on B-cell and T-cell vaccine responses.

Entities:  

Mesh:

Substances:

Year:  1998        PMID: 9855423

Source DB:  PubMed          Journal:  Dev Biol Stand        ISSN: 0301-5149


  7 in total

1.  Protective T-cell-based immunity induced in neonatal mice by a single replicative cycle of herpes simplex virus.

Authors:  M Franchini; C Abril; C Schwerdel; C Ruedl; M Ackermann; M Suter
Journal:  J Virol       Date:  2001-01       Impact factor: 5.103

Review 2.  Targeting RSV with vaccines and small molecule drugs.

Authors:  Heather M Costello; William C Ray; Supranee Chaiwatpongsakorn; Mark E Peeples
Journal:  Infect Disord Drug Targets       Date:  2012-04

3.  Human parainfluenza virus type 3 (PIV3) expressing the hemagglutinin protein of measles virus provides a potential method for immunization against measles virus and PIV3 in early infancy.

Authors:  A P Durbin; M H Skiadopoulos; J M McAuliffe; J M Riggs; S R Surman; P L Collins; B R Murphy
Journal:  J Virol       Date:  2000-08       Impact factor: 5.103

4.  Randomized clinical trial of the safety and immunogenicity of the Tdap vaccine in pregnant Mexican women.

Authors:  Jesús Zacarías Villarreal Pérez; José Manuel Ramírez Aranda; Manuel de la O Cavazos; Michelle de J Zamudio Osuna; José Perales Dávila; María Romelia Ballesteros Elizondo; Marco Vinicio Gómez Meza; Francisco Javier García Elizondo; Azucena M Rodríguez González
Journal:  Hum Vaccin Immunother       Date:  2017-01-02       Impact factor: 3.452

5.  Recombinant pro-apoptotic Mycobacterium tuberculosis generates CD8+ T cell responses against human immunodeficiency virus type 1 Env and M. tuberculosis in neonatal mice.

Authors:  Uma Devi K Ranganathan; Michelle H Larsen; John Kim; Steven A Porcelli; William R Jacobs; Glenn J Fennelly
Journal:  Vaccine       Date:  2009-10-04       Impact factor: 3.641

6.  Safety and immunogenicity of a delta inulin-adjuvanted inactivated Japanese encephalitis virus vaccine in pregnant mares and foals.

Authors:  Helle Bielefeldt-Ohmann; Natalie A Prow; Wenqi Wang; Cindy S E Tan; Mitchell Coyle; Alysha Douma; Jody Hobson-Peters; Lisa Kidd; Roy A Hall; Nikolai Petrovsky
Journal:  Vet Res       Date:  2014-12-17       Impact factor: 3.683

7.  Defining the vaccination window for respiratory syncytial virus (RSV) using age-seroprevalence data for children in Kilifi, Kenya.

Authors:  Joyce U Nyiro; Ivy K Kombe; Charles J Sande; James Kipkoech; Patience K Kiyuka; Clayton O Onyango; Patrick K Munywoki; Timothy M Kinyanjui; D James Nokes
Journal:  PLoS One       Date:  2017-05-22       Impact factor: 3.240

  7 in total

北京卡尤迪生物科技股份有限公司 © 2022-2023.